Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Rating) was the target of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 47,200 shares, a growth of 9,340.0% from the May 15th total of 500 shares. Based on an average trading volume of 389,600 shares, the […]
Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies […]
Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. […]
Bavarian Nordic A/S (OTCMKTS: BVNRY) recently received a number of ratings updates from brokerages and research firms: 5/16/2022 – Bavarian Nordic A/S was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and […]
Zacks Investment Research cut shares of Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Rating) from a hold rating to a sell rating in a report published on Monday, Zacks.com reports. According to Zacks, “Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. […]